Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
The lancet. Gastroenterology & hepatology - 8(2023), 12 vom: 09. Dez., Seite 1074-1075 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Quan, Joshua [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 13.11.2023 Date Revised 13.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/S2468-1253(23)00310-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36306267X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36306267X | ||
| 003 | DE-627 | ||
| 005 | 20231226092542.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2468-1253(23)00310-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1210.xml |
| 035 | |a (DE-627)NLM36306267X | ||
| 035 | |a (NLM)37813111 | ||
| 035 | |a (PII)S2468-1253(23)00310-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Quan, Joshua |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.11.2023 | ||
| 500 | |a Date Revised 13.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Markovinović, Ante |e verfasserin |4 aut | |
| 700 | 1 | |a Hracs, Lindsay |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Panaccione, Remo |e verfasserin |4 aut | |
| 700 | 1 | |a Kaplan, Gilaad G |e verfasserin |4 aut | |
| 700 | 0 | |a STOP COVID-19 in IBD Research Group |e verfasserin |4 aut | |
| 700 | 1 | |a Benchimol, Eric I |e investigator |4 oth | |
| 700 | 1 | |a Bernatsky, Sasha |e investigator |4 oth | |
| 700 | 1 | |a Bindra, Gurmeet |e investigator |4 oth | |
| 700 | 1 | |a Bernstein, Charles N |e investigator |4 oth | |
| 700 | 1 | |a Caplan, Léa |e investigator |4 oth | |
| 700 | 1 | |a Charlton, Carmen |e investigator |4 oth | |
| 700 | 1 | |a Coward, Stephanie |e investigator |4 oth | |
| 700 | 1 | |a Ernest-Suarez, Kenneth |e investigator |4 oth | |
| 700 | 1 | |a Herauf, Michelle |e investigator |4 oth | |
| 700 | 1 | |a Holodinsky, Jessalyn K |e investigator |4 oth | |
| 700 | 1 | |a Ingram, Richard J M |e investigator |4 oth | |
| 700 | 1 | |a Kanji, Jamil N |e investigator |4 oth | |
| 700 | 1 | |a Kuenzig, M Ellen |e investigator |4 oth | |
| 700 | 1 | |a Lu, Cathy |e investigator |4 oth | |
| 700 | 1 | |a Mahoney, Douglas J |e investigator |4 oth | |
| 700 | 1 | |a Novak, Kerri |e investigator |4 oth | |
| 700 | 1 | |a Rowan, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Seow, Cynthia H |e investigator |4 oth | |
| 700 | 1 | |a Sharifi, Nastaran |e investigator |4 oth | |
| 700 | 1 | |a Tipples, Graham |e investigator |4 oth | |
| 700 | 1 | |a Turnbull, LeeAnn |e investigator |4 oth | |
| 700 | 1 | |a Windsor, Joseph W |e investigator |4 oth | |
| 700 | 1 | |a Yeaman, Fiona |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet. Gastroenterology & hepatology |d 2016 |g 8(2023), 12 vom: 09. Dez., Seite 1074-1075 |w (DE-627)NLM264051246 |x 2468-1253 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2023 |g number:12 |g day:09 |g month:12 |g pages:1074-1075 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S2468-1253(23)00310-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2023 |e 12 |b 09 |c 12 |h 1074-1075 | ||